GoodRx is now publicly available to trade. The stock opened at $46, nearly 40% above it's IPO price of $33.
Launched in 2011, GoodRx allows customers to compare prescription drug prices. It's since become a household name, which may be one of the reasons that the stock has been getting so much buzz. If you're planning to invest, here's how you can buy in.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $8.74 |
|---|---|
| 52-week range | $4.14 - $9.37 |
| 50-day moving average | $7.89 |
| 200-day moving average | $6.74 |
| Wall St. target price | $9.49 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.01 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $8.74 from 2024-07-25
| 1 week (2024-07-19) | 2.82% |
|---|---|
| 1 month (2024-06-27) | 13.65% |
| 3 months (2024-04-26) | 21.56% |
| 6 months (2024-01-26) | 34.67% |
| 1 year (2023-07-27) | 31.63% |
|---|---|
| 2 years (2022-07-27) | 37.85% |
| 3 years (2021-07-27) | 31.69 |
| 5 years (2019-07-23) | N/A |
Valuing GoodRx stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of GoodRx's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
GoodRx's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $77.1 million.
The EBITDA is a measure of a GoodRx's overall financial performance and is widely used to measure a its profitability.
To put GoodRx's EBITDA into context you can compare it against that of similar companies.
| Revenue TTM | $764.2 million |
|---|---|
| Operating margin TTM | 10.3% |
| Gross profit TTM | $701.5 million |
| Return on assets TTM | 2.41% |
| Return on equity TTM | -0.9% |
| Profit margin | -0.86% |
| Book value | $1.68 |
| Market Capitalization | $3.2 billion |
TTM: trailing 12 months
We're not expecting GoodRx to pay a dividend over the next 12 months.
You may also wish to consider:
Over the last 12 months, GoodRx's shares have ranged in value from as little as $4.135 up to $9.37. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while GoodRx's is 1.401. This would suggest that GoodRx's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
To put GoodRx's beta into context you can compare it against those of similar companies.
GoodRx Holdings, Inc. , together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California. .
Steps to owning and managing ZTEK, with 24-hour and historical pricing before you buy.
Steps to owning and managing MYNZ, with 24-hour and historical pricing before you buy.
Steps to owning and managing ATAI, with 24-hour and historical pricing before you buy.
Steps to owning and managing OWLT, with 24-hour and historical pricing before you buy.
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
Steps to owning and managing HUM, with 24-hour and historical pricing before you buy.
Steps to owning and managing ILMN, with 24-hour and historical pricing before you buy.
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.